Off-Label Use of Ruxolitinib In Refractory Graft-Versus-Host Disease After Allogenic Stem Cell Transplantation

Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1325
https://www.valueinhealthjournal.com/article/S1098-3015(16)32691-2/fulltext
Title : Off-Label Use of Ruxolitinib In Refractory Graft-Versus-Host Disease After Allogenic Stem Cell Transplantation
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32691-2&doi=10.1016/j.jval.2016.09.1325
First page : A576
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 1245
Categories :
Tags :
Regions :
ViH Article Tags :